Release Date: September 6, 2012
National Cancer Institute (NCI)
This Notice is to inform potential applicants that the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has joined PA-12-271, entitled “Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01).”
Part 1: Overview Information
Components of Participating Organizations
The Components of Participating Organizations section of PA-12-271 is hereby revised to include the NCI:
Catalog of Domestic Assistance (CDFA) Number
Part 2: Full Text of Announcement
Section I. Funding Opportunity Description
The Funding Opportunity Description of PA-12-271 is hereby revised to state that the NCI is especially interested in studies that address relevant research questions presented in the funding opportunity announcement (FOA) that also pertain to mechanisms of action of how metformin may modify cancer risk or cancer-related mortality. Such studies may involve analyses of surrogate biomarkers.
All other aspects of the FOA remain unchanged.
Please direct all inquiries to:
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Division of Cancer Prevention
National Cancer Institute
6130 Executive Boulevard, EPN Room 2129
Bethesda, MD 20892-7333
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.